Literature DB >> 22476858

Impact of the positive pathergy test on the performance of classification/diagnosis criteria for Behcet's disease.

Fereydoun Davatchi1, Bahar Sadeghi Abdollahi, Cheyda Chams-Davatchi, Farhad Shahram, Zahra Ghodsi, Abdolhadi Nadji, Massoomeh Akhlaghi, Tahereh Faezi, Hormoz Shams, Roghieh Larimi, Farima Ashofteh.   

Abstract

BACKGROUND: The only diagnostic test that currently exists for Behcet's disease (BD) is the pathergy test. A positive pathergy test (PPT) is an important component of many of the 16 sets of classification/diagnosis criteria used to diagnose BD. The aim of this study was to determine the importance of a PTT in the performance of the diagnosis/classification criteria for BD. PATIENTS AND METHODS: All patients listed in the BD registry of the Rheumatology Research Center, Tehran (6,727) and 4,648 BD controls were enrolled in the study. The diagnosis was clinical when no other diagnosis could explain the patient's manifestations. The criteria were tested with and without PPT results. Sensitivity, specificity, and accuracy were calculated.
RESULTS: Without PPT, all sets of criteria lost sensitivity, gained specificity, and lost accuracy, with the exception of the Cheng-Zhang criteria. The largest loss in sensitivity was for the Hubault-Hamza (35 %) and Dilsen (17.3 %) criteria; the least was for the Curth (1.9 %) and ICBD (6.5 %) criteria. The largest gain on specificity was for the Dilsen (4.7 %) and Curth (3.1 %) criteria; the least was for the Japan (0.1 %) and Japan revised (0.1 %) criteria. The greatest loss in accuracy was for the Hubault-Hamza (20.4 %) and Dilsen revised (9.3 %) criteria; the least was for the ICBD (3.6 %), while Curth gained 0.3 %.
CONCLUSION: Without PPT as a criterion for the diagnosis of BD, the sensitivity and accuracy of the sets of classification/diagnosis criteria decrease, while the specificity improves.

Entities:  

Mesh:

Year:  2012        PMID: 22476858     DOI: 10.1007/s10165-012-0626-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

Review 1.  Diagnostic/classification criteria in pediatric Behçet's disease.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-11-14       Impact factor: 2.631

Review 2.  Behcet's Syndrome.

Authors:  Sam R Dalvi; Resit Yildirim; Yusuf Yazici
Journal:  Drugs       Date:  2012-12-03       Impact factor: 9.546

3.  Pathergy testing: prospective comparison of dermatoscopic evaluation and naked eye examination.

Authors:  Aysegul Sevim Kecici; Zekayi Kutlubay; Server Serdaroglu; Yalcin Tuzun
Journal:  Intern Emerg Med       Date:  2019-02-08       Impact factor: 3.397

4.  Morbus Behçet - a rare disease in Central Europe.

Authors:  Anna Woźniacka; Anna Sysa-Jędrzejowska; Piotr Jurowski; Maciej Jabłkowski; Marek Kot
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

Review 5.  Behçet's disease: review with emphasis on dermatological aspects.

Authors:  Maria Antonieta Rios Scherrer; Vanessa Barreto Rocha; Lucas Campos Garcia
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

Review 6.  Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.

Authors:  Bruno Fortaleza de Aquino Ferreira; Ever Ernesto Caso Rodriguez; Leandro Lara do Prado; Celio Roberto Gonçalves; Carlos Eduardo Hirata; Joyce Hisae Yamamoto
Journal:  J Med Case Rep       Date:  2017-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.